Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Alopecia areata causes significant financial strain, especially for women and those with severe symptoms.

Androgenetic alopecia significantly lowers self-esteem and affects social interactions.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Balding people may have higher heart disease risk.

Androgenetic alopecia causes hair loss, affects men more severely, and treatments are only temporarily effective.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

Androgenetic alopecia negatively impacts mental health, suggesting a need for psychological support in treatment.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

A new treatment for hair loss shows promise with fewer side effects.

Most patients with hair loss used alternative treatments, especially topical applications and health food supplements, based on recommendations from others.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Current treatments for common male hair loss have limited effectiveness and can cause side effects.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Immune activities and specific genes are important in male pattern baldness.